Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run
Key takeaways
- Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold.
- See, I kept thinking that there would be a consolidator and Stryker would do the consolidating and J&J’s spinning off its orthopedics, too.
- Stryker Corporation (NYSE:SYK) supplies medical technologies, including surgical equipment, joint replacement implants, robotic applications, and AI-assisted virtual care platforms.
Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run Syeda Seirut Javed Sat, June 20, 2026 at 8:40 PM GMT+7 2 min read SYK JNJ Stryker Corporation (NYSE:SYK) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold. In response, Cramer said:
See, I kept thinking that there would be a consolidator and Stryker would do the consolidating and J&J’s spinning off its orthopedics, too. And it has not come true… And I’m kind of bummed because I thought that that group, which was Zimmer, Biomet, and Stryker, I thought they would work out something, and they haven’t, and it’s been a real tough run.
A stock market graph. Photo by energepic.com